Simplified medical abortion using a semi-quantitative pregnancy test for home-based follow-up  by Lynd, Kelsey et al.
International Journal of Gynecology and Obstetrics 121 (2013) 144–148
Contents lists available at SciVerse ScienceDirect
International Journal of Gynecology and Obstetrics
j ourna l homepage: www.e lsev ie r .com/ locate / i jgoCLINICAL ARTICLE
Simpliﬁed medical abortion using a semi-quantitative pregnancy test for
home-based follow-up
Kelsey Lynd a, Jennifer Blum b,⁎, Nguyen Thi Nhu Ngoc c, Tara Shochet d,
Paul D. Blumenthal a, Beverly Winikoff b
a Stanford University Medical Center, Stanford, USA
b Gynuity Health Projects, New York, USA
c Center for Research and Consultancy in Reproductive Health, Ho Chi Minh City, Vietnam
d Consultant, Iowa City, USA⁎ Corresponding author at: Gynuity Health Projects, New
212 448 1230; fax: +1 212 448 1260.
E-mail address: jblum@gynuity.org (J. Blum).
0020-7292/$ – see front matter © 2013 International Fed
http://dx.doi.org/10.1016/j.ijgo.2012.11.022a b s t r a c ta r t i c l e i n f oArticle history:
Received 2 July 2012
Received in revised form 14 November 2012
Accepted 23 January 2013
Keywords:
Abortion
Human chorionic gonadotropin
Medical abortion
Pregnancy test
Objective: To simplify follow-up after medical abortion by examining whether women could use a semi-
quantitative pregnancy test at home to screen for ongoing pregnancy.Methods: Three hundred women seek-
ing medical abortion at a tertiary hospital in Vietnam participated in the study. Participants used a semi-
quantitative pregnancy test at the hospital to estimate baseline human chorionic gonadotropin (hCG) levels
and administered another test at home 2 weeks later for comparison. Women interpreted the test result at
home and then returned to hospital for follow-up care. At this visit, self-assessment was veriﬁed. To assess
further the feasibility of the test as a follow-up tool in service delivery, 200 additional women completed a
user comprehension survey. Results: The tests identiﬁed all 11 ongoing pregnancies among study participants
(100% sensitivity; 89.7% speciﬁcity). Women reported that the test was easy to use (255/292 [87.3%]) and
that provider instructions helped them to use the test (291/292 [99.7%]). Conclusion: Semi-quantitative preg-
nancy tests offer high sensitivity and negative predictive value. If user instructions can be further simpliﬁed,
the tests could be used in lieu of transvaginal ultrasound and/or serum hCG at clinic-based follow-up or by
women themselves for home-based follow-up.
Clinical trials.gov: NCT01150279
© 2013 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.1. Introduction
Common practice for medical abortion includes clinic-based follow-
up and clinical assessment, including transvaginal ultrasound, to deter-
mineabortion status. This follow-up visit can be costly and time consum-
ing for both the healthcare system and the woman [1,2]. As medical
abortion becomesmorewidely used,manywomen simply do not return
to the clinic to receive clinician conﬁrmation of complete abortion. Pro-
viding women with a safe, effective, and affordable at-home diagnostic
tool to conﬁrm whether a pregnancy is ongoing after administration of
mifepristone andmisoprostol could reduce costs and simplify the proce-
dure by limiting the number of clinic visits and costly exams, and reduc-
ing waiting time. Ideally, during her initial clinic visit, a woman would
receivemisoprostol, a pregnancy test, and counseling on how tomanage
her abortion at home. With these tools, the majority of women could
manage their abortion at home on their own. With this objective in
mind, providers and researchers have exploredways to simplifymedicalYork, NY 10010, USA. Tel.: +1
eration of Gynecology and Obstetrics.abortion follow-upwith serial human chorionic gonadotropin (hCG) test-
ing, high- and low-sensitivity pregnancy tests, and telephone or other
virtual follow-up [3–7].
Quantitative serum hCG testing to conﬁrm abortion completion is
commonly used in the USA and Europe. Previous research has docu-
mented change in hCG level after medical abortion [6,8–10]. Since
2005, Planned Parenthood Federation of America has waived the
follow-up visit if it poses undue hardships owing to distances from
abortion facilities or other reasons, and women manage their follow-
upwith serial hCG testing [11]. This method of follow-up has proven ef-
fective because ongoing pregnancies exhibit increasing hCG levels (hCG
levels that donot increase in the 2 weeks aftermifepristone administra-
tion indicate that no viable pregnancy is present). In general, in the
event of a successful medical abortion, the hCG level decreases by at
least half of its pretreatment levelwithin aweek ofmifepristone admin-
istration [12]. Service delivery programs seeking to integrate serumhCG
testing into medical abortion follow-up services must conﬁrm that it is
acceptable and affordable to women and compatible with the infra-
structure and human resources available. In some instances, laboratory
conﬁrmation of hCG results can be delayed for hours or days, depending
on the location of the laboratory and the volume of specimens pro-
cessed. This delaymight be incompatible with efﬁcient service delivery.Published by Elsevier Ireland Ltd. All rights reserved.
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low-resource settings, serum hCG testing is not yet widely available.
Urine pregnancy tests offer another way to measure hCG level.
Several studies have documented that urine hCG level is highly
correlated with serum hCG level in conﬁrming pregnancy status
[3,4,13]. Other research has modeled various algorithms to conﬁrm
abortion success using patient symptoms and a low-sensitivity urine
pregnancy test [14]. Grossman et al. [7] reviewed published studies ex-
amining alternatives to follow-up, including serial hCG testing, urine
pregnancy tests, and telephone interview. The authors concluded that
alternative follow-up modalities could successfully identify ongoing
pregnancy and proposed that further research examine service delivery
options that include both at-home urine pregnancy tests and self- or
clinician assessment.
In an effort to offer something potentially less costly and less inva-
sive than serum hCG testing or sonography but more informative
than a simple low-sensitivity pregnancy test, the aim of the present
study was to investigate the feasibility of Vietnamese women per-
forming a semi-quantitative pregnancy test at home, on their own,
to determine their abortion status.2. Materials and methods
From September 14, 2009, to April 2, 2010, 300 women presenting
for medical abortion with pregnancies dated up to 63 days since last
menstrual period were recruited at a large tertiary facility in Ho Chi
Minh City, Vietnam. Additional inclusion criteria were intrauterine
pregnancy; no known contraindications to abortion with mifepris-
tone and/or misoprostol; general good health; ability to provide in-
formed consent; and willingness to return for follow-up.
Study clinical staff identiﬁed potential participants and offered
them enrollment. After the consent and screening process was com-
pleted, study staff taught participants how to perform the urine-
based semi-quantitative pregnancy test. The result of this initial
test, carried out prior to mifepristone administration, located the
range of each participant's hCG level before abortion. A 5-bracketed
semi-quantitative immunochromatographic assay panel (dBest hCG
Panel Test; Ameritek, Seattle, WA, USA) was used (Fig. 1). The test
operates as both a high-sensitivity (at least 25-mIU/mL reading) and a
low-sensitivity (at least 2000-mIU/mL and at least 10 000-mIU/mLFig. 1. The dBest (Ameritek, Seattle, WA, USA) semi-quantitative pregnancy test show-
ing a reading of 500 mIU/mL of human chorionic gonadotropin (hCG). C denotes con-
trol line. A control line indicates that the test strip has been properly saturated with
urine. A control line must appear in all 5 columns for the test to be considered valid. T
denotes test line. A test line indicates a positive test result. A column with 1 line (a C line
but not a T line) is indicative of a negative test reading. A column consisting of 2 lines (a
C line and a T line) indicates a positive test reading for the speciﬁc level of hCG.reading) test, in addition to providing readings at 2 other ranges
(>100 mIU/mL and >500 mIU/mL). The test offers a technical im-
provement compared with other pregnancy tests because it provides
greater precision to help minimize the likelihood of false-negative re-
sults and, uniquely, provides information about the trend in hCG level,
which can be compared with the pre-abortion level for each woman.
Tests were conducted by dipping the test strip into a urine cup and stir-
ring the strips for at least 10 seconds to saturate the test thoroughly.
Training emphasized the need to stir and soak the panel to achieve sat-
uration. The tests were then placed face-up on a ﬂat surface and read
15 minutes later.
Each womanwas provided with misoprostol for home administra-
tion, a second semi-quantitative pregnancy test, a urine sample cup,
an instruction sheet, and a questionnaire to take home. Participants
administered misoprostol at home 1–2 days later. Women were
instructed to take the test and complete the form on the morning of
their follow-up visit, which was approximately 2 weeks after mifep-
ristone administration. Either ﬁrst morning urine or random urine
could be used. Emphasis was placed on the importance of saturating
all 5 paper strips and waiting at least 15 minutes before reading the
tests. The instruction sheet included information on how to read the
test and pictorial images of each possible result, as well as a list of
commonly asked questions with responses.
Regardless of the results of the pregnancy test conducted at home,
each participant was scheduled for clinic-based follow-up. Participants
were asked to bring their completed pregnancy tests and study ques-
tionnaires with them to this visit. Clinicians then documented the result
of the at-homepregnancy tests and assessed each participant's abortion
status using standard clinical means, including physical examination
and/or transvaginal ultrasound. The results of this standard clinic-
based examination were used to determine whether additional care
was needed. Women who forgot to complete the at-home pregnancy
test or for whom the at-home test showed an inconclusive result were
given an additional test to perform at the clinic.
A user comprehension survey was also conducted among 200 addi-
tional women of any age from the patient waiting area to ascertain
whether potential users understood how to use and interpret the test.
Participants were randomly provided with a sample semi-quantitative
pregnancy test that indicated 1 of the 5 possible results, the instruction
sheet, and a questionnaire. Women were asked to use the instruction
sheet to interpret the test results and to complete the questionnaire.
The primary outcome of the clinical study was the feasibility of
using the test as part of follow-up for medical abortion. To that end,
we documented whether the tests identiﬁed all ongoing pregnancies
(the main outcome of interest) and whether participants were able
to interpret the test correctly. Clinician assessment, via pregnancy
test or ultrasound/clinical examination, determined abortion status;
semi-quantitative pregnancy test results were evaluated in compari-
son with this assessment. The primary outcomes of the user compre-
hension study were the ability to both understand and interpret the
test. Data entry and analysis were performed using SPSS version 15
(IBM, Armonk, NY, USA) and STATA version 11 (StataCorp, College
Station, TX, USA). Sensitivity/speciﬁcity and positive/negative predic-
tive values were calculated to assess the accuracy of the pregnancy
test in identifying ongoing pregnancies. Because the main outcome
of interest—identiﬁcation of ongoing pregnancy—would be rare fol-
lowing early medical abortion with mifepristone and misoprostol, it
was determined that 300 participants for the clinical study and 200
participants for the user comprehension study would be sufﬁcient
for assessing the feasibility of the test in medical abortion care. Ethics
approval was provided by Hung Vuong Hospital, Ho Chi Minh City.
3. Results
On average, participants were 29 years of age and most had a sec-
ondary education or higher (Table 1). Medical abortionwas successful
Table 2
Sensitivity/speciﬁcity and positive/negative predictive values of SQPT to detect ongoing
pregnancy versus all other outcomes based on user reading in the clinical study.a
Ongoing pregnancy All other outcomes
Test indicated steady or
increasing hCG level, or test
inconclusiveb
100.0% (11/11) 10.3% (29/281)
Test indicated decreasing hCG
level
0.0% (0/11) 89.7% (252/281)
Sensitivity: 100.0% Speciﬁcity: 89.7%
Positive predictive value: 27.5% Negative predictive value: 100.0%
Abbreviations: hCG, human chorionic gonadotropin; SQPT, semi-quantitative pregnan-
cy test.
a User reading unavailable for 1 woman for whom home pregnancy test data were
not available.
b All 6 women with inconclusive test results had successful medical abortions with
no additional intervention.
Table 1
Clinical participant characteristics (n=300).a
Characteristic Value
Age, y 29±6 (18–44)
Education completed
Primary school (1–5 years) 10 (3.3)
Secondary school (6–12 years) 232 (77.3)
University level or higher 58 (19.3)
Gestational age, d 42.4±5.9 (30–64)
Medical abortion outcomeb
Complete abortion 275 (93.9)
Surgical intervention 18 (6.1)
Ongoing pregnancy 11 (3.8)
Medically indicated (persistent/heavy bleeding) 2 (0.7)
Persistent non-viable pregnancy or sac 4 (1.4)
Provider or woman's preference 1 (0.3)
Participant thought she was still pregnant (or was unsure)
prior to taking at-home testc
54 (18.5)
Participant had complete medical abortion 41 (75.9)
Participant had surgical intervention 13 (24.1)
a Values are given as mean±SD (range) or number (percentage).
b Data do not include 4 women who were lost to follow-up and 3 women who left
the study early.
c Data do not include 4 women who were lost to follow-up, 3 women who left the
study early, and 1 woman with successful medical abortion who did not return her
home questionnaire.
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gical intervention owing to: ongoing pregnancy (11 [3.8%]); bleeding
(2 [0.7%]); persistent non-viable pregnancy or sac (4 [1.4%]); or pro-
vider or woman's preference (1 [0.3%]). Fig. 2 shows the trial proﬁle.ANALYZED WITH ALL DATA AVAILABLE (n=293) 
ANALYZED, AT-HOME FOLLOW-UP PREGNANCY TEST 
DATA AVAILABLE (n=286) 
 
At-home pregnancy test data not available, inconclusive result 
(n=6) 
At-home pregnancy test data missing (n=1) 
All available data included in the analysis 
TWO-WEEK FOLLOW-UP AT CLINIC 
(n=293) 
Follow-up prior to 2 weeks (n=0) 
Lost to follow-up (n=4) 
MISOPROSTOL ADMINISTERED AT 
HOME (n=297) 
Did not administer misoprostol/changed 
mind about taking drug (n=3) 
MIFEPRISTONE ADMINISTERED & 
BASELINE PREGNANCY TEST DONE 
(n=300) 
SCREENED & ENROLLED 
(n=300) 
PREGNANCY TEST DONE AT HOME 
(n=292) 
Fig. 2. Clinical trial proﬁle.On the morning of the follow-up visit, participants used the semi-
quantitative pregnancy test at home and recorded their interpreta-
tion of the result. Fifty-four of 292 (18.5%) participants reported
that they thought they were still pregnant prior to using the at-
home test (Table 1). The test identiﬁed all 11 ongoing pregnancies,
with 100% sensitivity (11/11) and 89.7% speciﬁcity (252/281) (Table 2).
In addition to identifying all of the ongoing pregnancies, the test did
not show a decrease in hCG level for an additional 29 women
(Table 3). Of these, 24 received no intervention at follow-up and 5
underwent treatment for persistent non-viable pregnancy or sac.
None of the participants whose tests showed a decrease in hCG level
from baseline to follow-up was later identiﬁed as having an ongoing
pregnancy. Four of 252 (1.6%) women who showed a reduction in
hCG level received interventions at the follow-up visit (Table 3).
Among the 11 women for whom the test identiﬁed an ongoing
pregnancy, 10 (90.9%) understood that an additional clinic visit was
needed. Of the 252 women whose test indicated that clinic-based
follow-up was not needed, 147 (58.3%) understood that no additional
visit was necessary. Most participants (255/292 [87.3%]) reported
that the test was “very easy” or “easy” to use. Nearly all participants
(291/292 [99.7%]) felt that the information given by providers helped
them use the test.
Results from the user comprehension survey are shown in Table 4.
Participants had similar proﬁles to women participating in the clinical
study. When given a test with a pre-conﬁgured result and shown an
illustration of the 5 possible test outcomes, 195 (97.5%) women cor-
rectly matched the test they had been given with the correlating illus-
trated result. Education level did not impact the capacity of survey
participants to interpret the test correctly. In total, 190 of 195
(97.4%) women understood the numeric value of the test. Only 7
(3.5 %) women felt that the test was difﬁcult to use. Overall, 196
(98.0%) participants felt that they could use the test on their own in
the future; this perception was not impacted by education level.4. Discussion
The present results complement previous ﬁndings that urine hCG
testing can be used as part of early medical abortion follow-up [3–5].
The use of a semi-quantitative test instead of universal clinic-based
follow-up could signiﬁcantly impact medical abortion service deliv-
ery because the test could be used as at-home follow-up for women
living away from abortion facilities who may wish to avoid a
follow-up visit if not required. For women undergoing clinic-based
follow-up, the test could provide an alternative to transvaginal ultra-
sound (often repeated several times for each woman) as the primary
means for conﬁrming a complete medical abortion. A tool such as
the semi-quantitative pregnancy test could reduce the proportion of
women paying for and receiving ultrasound. It would also free-up
Table 3
Effectiveness and acceptability of SQPT in assessing medical abortion outcomes.
No. (%)
Intervention at follow-up among women whose at-home pregnancy test showed steady or increasing hCG level, or test was inconclusive (n=40)a
No intervention 24 (60.0)
Intervention performed 16 (40.0)
Ongoing pregnancy managed surgically 11 (27.5)
Persistent non-viable pregnancy or sac managed surgically or with additional dose of misoprostol 5 (12.5)
Intervention at follow-up among women whose at-home pregnancy test showed decreasing hCG level (n=252) a
No intervention 248 (98.4)
Intervention performed 4 (1.6)
Ongoing pregnancy managed surgically 0 (0.0)
Persistent non-viable pregnancy or sac managed surgically or with additional dose of misoprostol 1 (0.4)
Medically indicated (persistent/heavy bleeding) 2 (0.8)
Provider or woman's preference 1 (0.4)
SQPT reading identiﬁed ongoing pregnancy 11/11 (100.0)
Participant understood that this result meant that an additional clinic visit was needed 10 (90.9)
Participant did not understand that an additional clinic visit was needed 1 (9.1)
SQPT reading indicated that clinic-based follow-up was not needed 252/281 (89.7)
Participant understood that this result meant that no additional clinic visit was needed 147 (58.3)
Participant did not understand that no additional clinic visit was needed 105 (41.7)
Participant report on ease of use of test (n=292)
Test was neither easy nor difﬁcult 37 (12.7)
Test was “easy” to use 143 (49.0)
Test was “very easy” to use 112 (38.4)
Participant felt that the information given by providers helped them use the test (n=292) 291 (99.7)
Abbreviations: hCG, human chorionic gonadotropin; SQPT, semi-quantitative pregnancy test.
a Includes 14 of the 18 women who underwent surgical intervention (all 11 with ongoing pregnancies and 3 with persistent non-viable pregnancy or sac); the other 4 had preg-
nancy tests indicating a decrease in hCG level.
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necessary surgical completions for retained products of conception.
Such effects may be especially beneﬁcial in resource-poor countries,
where clinics may be overcrowded and understaffed, with limited ac-
cess to serum hCG testing and ultrasound.
The semi-quantitative pregnancy test, with its 5-bracketed ranges,
enabled ongoing pregnancy to be ruled out earlier than in previous
studies using high- or low-sensitivity pregnancy tests. For instance,
Perriera et al. [5] investigated the at-home use of a high-sensitivity
pregnancy test 4 weeks after mifepristone administration as part of
a telephone follow-up study. Nearly three-quarters of participants
were able to avoid clinic-based follow-up; however, they had to
wait 4 weeks to conﬁrm that their abortion was complete [5]. In the
present study, women were able to conﬁrm their abortion outcomeTable 4
Results of user comprehension survey (n=200).a,b
Characteristic Value
Age, y 31±8 (18–55)
Education completed
Primary school (1–5 years) 26 (13.0)
Secondary school (6–12 years) 130 (65.0)
University level or higher 44 (22.0)
Pregnancy test was matched with correct corresponding image 195 (97.5)
Among women with less than college degree 151/156 (96.8)
Among women with college degree or higher 44/44 (100.0)
Understood numeric value of test 190/195 (97.4)
Among women with less than college degree 147/151 (97.4)
Among women with college degree or higher 43/44 (97.7)
Instruction sheet helped with interpreting pregnancy test results 198/199 (99.5)
Test was easy to use
Very easy/easy 100 (50.0)
Neither easy nor difﬁcult 93 (46.5)
Difﬁcult/very difﬁcult 7 (3.5)
Woman believed she could use test on her own in the future to
determine pregnancy status
196 (98.0)
Among women with less than college degree 153/156 (98.1)
Among women with college degree or higher 43/44 (97.7)
a Values are given as mean±SD (range) or number (percentage).
b Participants in the user comprehension survey were not the same women as in the
clinical study.2 weeks after mifepristone administration. In another study using the
same semi-quantitative pregnancy test, women in the USA obtained re-
sults using the test just 1 week after mifepristone administration [15].
The semi-quantitative pregnancy test enables women to ﬁnd out their
abortion status sooner, thereby shortening the duration of the procedure.
Furthermore, in the rare event of a continued ongoing pregnancy after
early medical abortion, diagnosis of a growing embryo 1 to 2 weeks
after mifepristone administration facilitates earlier clinical action.
The potential feasibility of using this test in resource-poor settings
is underscored by the fact that nearly all of the participants in both the
clinical study and the user comprehension survey reported that the
test was easy to use. It should be noted, however, that most of the par-
ticipants in the present study had completed at least secondary-school
education. Despite the nearly unanimous responses that the test was
easy to use, when asked to interpret their own test results, nearly
half of the womenwith a decrease in hCG level were not sure whether
they needed clinic-based follow-up. Interestingly, an increase or no
change in hCG level seemed to be more easily understandable for
participants: nearly all (90.9%) of those with ongoing pregnancy cor-
rectly interpreted their results. Future simpliﬁcations of the instruc-
tions sheet should help to improve user comprehension in this
regard. Upon discussion with the study investigators, we hypothesize
that the design of the study protocol—stipulating that all womenmust
return for follow-up—may have confused women when asked to
respond to the question of whether they felt they “needed” to return
for follow-up.
The present study was limited by its small sample size and geo-
graphic speciﬁcity to a single hospital in 1 country, with results that
may not be generalizable to other settings. The small sample size
meant that potential differences in the cohort could not be examined;
instead, the feasibility of this potential service delivery innovation
was examined and information was collected from which larger pro-
spective studies could be conducted.
Future research should document how post-abortion contracep-
tion can be integrated into medical abortion services with at-home
follow-up protocols. More operational research to document “virtual”
reporting of at-home follow-up using cellular phones and/or the
Internet could also reveal the beneﬁts of this type of service delivery
in a range of settings.
148 K. Lynd et al. / International Journal of Gynecology and Obstetrics 121 (2013) 144–148Allowing women the option to use semi-quantitative pregnancy
tests as at-home tools in lieu of clinic-based follow-upwith ultrasound
has potential for signiﬁcant cost-savings for both the healthcare sys-
tem and women. Yet, for this to be realized, the test must be widely
available and at a low cost. Currently, only 1 manufacturer produces
the semi-quantitative pregnancy test, meaning that wide availability
is inhibited. Future efforts should seek to increase access to this prom-
ising technology.
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